RPH-203

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRPH-203

Drug Alias NameRPH-203

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionTumor necrosis factor ligand superfamily member 11 inhibitors

TargetsTumor necrosis factor ligand superfamily member 11

Therapy Area/IndicationsOsteoporosisBone Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesR-Pharm Jsc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesR-Pharm Jsc

Active IndicationsN/A

Inactive IndicationsOsteoporosisBone Neoplasms

ATC CodeN/A